Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Momenta Pharmaceuticals Inc.

www.momentapharma.com

Latest From Momenta Pharmaceuticals Inc.

Momenta Pays Out On Enoxaparin Shut-Out

Momenta Pharmaceuticals has agreed to pay $35.0m to settle claims that it manipulated generic approval processes in the US to shut competitor Amphastar out of the US enoxaparin market.

Legal Issues Private Payers

Pfizer’s FDA-Approved Adalimumab Faces Four-Year Wait

Pfizer has secured FDA approval for its adalimumab biosimilar under the name Abrilada, representing the agency’s 25th biosimilar approval overall. However, patent settlements around the Humira brand mean that Pfizer is not due to enter the market for four years.

Biosimilars United States

Strides Plans Re-Entry On Injectables

Indian firm Strides to invest up to $40m in acquired Stelis for re-entry into generic injectables and multiple biosimilar APIs as it looks to build its business.

Commercial Strategy

Strides Plans Injectables Re-entry As Mylan Non-Compete Nears End

Indian firm Strides to invest up to $40m in acquired Stelis for re-entry into generic injectables and multiple biosimilar APIs as it looks to build its business.  

Commercial Strategy
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Mimeon Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Momenta Pharmaceuticals Inc.
  • Senior Management
  • Craig A Wheeler, Pres. & CEO
    Michelle Robertson, CFO
    Young T Kwon, PhD, CBO
    Santiago Arroyo, MD, PhD, SVP, Dev. & CMO
    Anthony Manning, CSO
  • Contact Info
  • Momenta Pharmaceuticals Inc.
    Phone: (617) 491-9700
    301 Binney St.
    Cambridge, MA 02142
    USA
UsernamePublicRestriction

Register